Clinical Research Directory
Browse clinical research sites, groups, and studies.
Minimally Invasive Pelvic Exenteration in Vaginal or Cervical Cancer Recurrence
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Summary
The aim of this clinical trial is to assess the oncologic safety of minimally invasive pelvic exenteration in patients with recurrence or persistence of cervical or vaginal cancer with pelvic location, suitable for pelvic exenteration according to the ESGO guidelines (European Society of Gynecological Oncology). The primary aim is to assess the 3-year disease-free survival (DFS). The secondary aim is to assess the 3-year overall survival (OS), the intraoperative and post-operative complication rate, and the patient's quality of life.
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
64
Start Date
2025-07-07
Completion Date
2031-03-01
Last Updated
2025-07-17
Healthy Volunteers
No
Conditions
Interventions
Minimally invasive pelvic exenteration
If all criteria are met, patients are registered. The patient is enrolled before the surgery, at the time of pelvic evaluation under anaesthesia. A diagnostic laparoscopic assessment can be performed before the operation to exclude peritoneal metastasis. The experimental procedure in this protocol involves the use of a minimally invasive approach (robot-assisted or laparoscopic) for performing pelvic exenteration.
Locations (1)
Policlinico Agostino Gemelli IRCCS
Rome, Italy